These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 23036130)
1. Active and inactive forms of matrix metalloproteinases 2 and 9 in cutaneous melanoma. Candrea E; Senila S; Tatomir C; Cosgarea R Int J Dermatol; 2014 May; 53(5):575-80. PubMed ID: 23036130 [TBL] [Abstract][Full Text] [Related]
2. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545 [TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines. Docampo MJ; Cabrera J; Rabanal RM; Bassols A Am J Vet Res; 2011 Aug; 72(8):1087-96. PubMed ID: 21801067 [TBL] [Abstract][Full Text] [Related]
4. Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression. Redondo P; Lloret P; Idoate M; Inoges S Clin Exp Dermatol; 2005 Sep; 30(5):541-5. PubMed ID: 16045689 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of heparanase and matrix metalloproteinase-9 in patients with cutaneous malignant melanoma. Chen Y; Chen Y; Huang L; Yu J J Dermatol; 2012 Apr; 39(4):339-43. PubMed ID: 22150440 [TBL] [Abstract][Full Text] [Related]
6. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188 [TBL] [Abstract][Full Text] [Related]
7. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment. Bérubé M; Deschambeault A; Boucher M; Germain L; Petitclerc E; Guérin SL Mol Vis; 2005 Dec; 11():1101-11. PubMed ID: 16379022 [TBL] [Abstract][Full Text] [Related]
8. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Nikkola J; Vihinen P; Vuoristo MS; Kellokumpu-Lehtinen P; Kähäri VM; Pyrhönen S Clin Cancer Res; 2005 Jul; 11(14):5158-66. PubMed ID: 16033831 [TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer]. Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745 [TBL] [Abstract][Full Text] [Related]
11. Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography. Kurschat P; Wickenhauser C; Groth W; Krieg T; Mauch C J Pathol; 2002 Jun; 197(2):179-87. PubMed ID: 12015741 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Patel BP; Shah SV; Shukla SN; Shah PM; Patel PS Head Neck; 2007 Jun; 29(6):564-72. PubMed ID: 17252594 [TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K; Shigemasa K; Nagai N; Ohama K Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of serum levels of matrix metallopeptidase-2, and tissue inhibitor of metalloproteinase-1 and -2 in patients with malignant melanoma. Yoshino Y; Kageshita T; Nakajima M; Funakubo M; Ihn H J Dermatol; 2008 Apr; 35(4):206-14. PubMed ID: 18419677 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma. Väisänen AH; Kallioinen M; Turpeenniemi-Hujanen T Hum Pathol; 2008 Mar; 39(3):377-85. PubMed ID: 18187184 [TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases 2 and 9 in situ mRNA expression in colorectal tumors from Iraqi patients. Ahmed MM; Mohammed SH Indian J Pathol Microbiol; 2011; 54(1):7-14. PubMed ID: 21393869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]